tirzepatide caremark cvs CVS says it will start covering Lilly's newly approved obesity pill Foundayo on https://bit.ly/45UTcvJ 🚨 Attention Zepbound Users!

Dagenais GR, Rydn L, Leiter LA, Lakshmanan M, Dyal L, Probstfield JL, Atisso CM, Shaw JE, Conget I, Cushman WC, Lopez-Jaramillo P, Lanas F, Munoz EGC, Pirags V, Pogosova N, Basile J, Sheu WHH, Temelkova-Kurktschiev T, Raubenheimer PJ, Keltai M, Hall S, Pais P, Colhoun HM, Riddle MC, Gerstein HC

Overall, both bimagrumab and tirzepatide have demonstrated promising safety in earlier research, suggesting they are generally well tolerated

A provider may recommend switching medications for several reasons: Switching should always occur under medical supervision

Note that technically, the versions of the medicines someone needs for obesity treatment are Zepbound and Wegovy

Ethical Approval No ethical approval was sought as this article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by the author